SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $657,000 | -2.7% | 7,301 | 0.0% | 0.02% | -7.7% |
| Q3 2021 | $675,000 | +18.8% | 7,301 | 0.0% | 0.03% | +18.2% |
| Q2 2021 | $568,000 | +4.4% | 7,301 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $544,000 | -34.5% | 7,301 | +49.9% | 0.02% | -38.9% |
| Q4 2020 | $830,000 | +18.1% | 4,870 | -2.7% | 0.04% | +12.5% |
| Q3 2020 | $703,000 | -15.7% | 5,003 | -3.8% | 0.03% | -25.6% |
| Q2 2020 | $834,000 | +2775.9% | 5,201 | +2211.6% | 0.04% | +4200.0% |
| Q4 2019 | $29,000 | -49.1% | 225 | -70.1% | 0.00% | -66.7% |
| Q3 2019 | $57,000 | – | 753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |